Glucagon-like peptide-1 Glucagon-like peptide-1 ( GLP-1 ) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide
The medication's primary gastrointestinal side effectsparticularly nausea, vomiting, and diarrheacan lead to dehydration if fluid intake is inadequate or losses are not appropriately replaced
Founded in 1999 and based in Dublin, Ohio, Quantum Health has earned numerous awards and honors, including being named among the Fastest-Growing Private Companies by Inc
Act early, not late The 5% rule applies here
Even so, because of the known side effects, the medication is always started at a low dose and periodically escalated following a fixed schedule, he says